Gilder Gagnon Howe & Co’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-39,372
| Closed | -$1.06M | – | 277 |
|
|
2024
Q2 | $1.06M | Buy |
39,372
+4,440
| +13% | +$92.4K | 0.01% | 204 |
|
|
2024
Q1 | $640K | Buy |
34,932
+14,946
| +75% | +$237K | 0.01% | 232 |
|
|
2023
Q4 | $245K | Buy |
19,986
+104
| +0.5% | +$975 | ﹤0.01% | 241 |
|
|
2023
Q3 | $298K | Buy |
19,882
+5,056
| +34% | +$105K | ﹤0.01% | 243 |
|
|
2023
Q2 | $482K | Buy |
14,826
+2,636
| +22% | +$96.3K | 0.01% | 248 |
|
|
2023
Q1 | $477K | Buy |
+12,190
| New | +$596K | 0.01% | 223 |
|
|
2021
Q4 | – | Sell |
-7,543
| Closed | -$415K | – | 442 |
|
|
2021
Q3 | $415K | Buy |
7,543
+1,282
| +20% | +$67.1K | ﹤0.01% | 352 |
|
|
2021
Q2 | $300K | Hold |
6,261
| – | – | ﹤0.01% | 360 |
|
|
2021
Q1 | $317K | Sell |
6,261
-112,121
| -95% | -$6.23M | ﹤0.01% | 329 |
|
|
2020
Q4 | $7.46M | Buy |
118,382
+654
| +0.6% | +$40.6K | 0.04% | 197 |
|
|
2020
Q3 | $7.91M | Sell |
117,728
-3,299
| -3% | -$180K | 0.05% | 178 |
|
|
2020
Q2 | $5.07M | Buy |
121,027
+40,595
| +50% | +$1.56M | 0.04% | 176 |
|
|
2020
Q1 | $2.53M | Sell |
80,432
-52,248
| -39% | -$2.09M | 0.03% | 172 |
|
|
2019
Q4 | $5.36M | Buy |
132,680
+57,175
| +76% | +$2M | 0.06% | 164 |
|
|
2019
Q3 | $2.46M | Buy |
75,505
+15,185
| +25% | +$605K | 0.03% | 196 |
|
|
2019
Q2 | $2.92M | Buy |
+60,320
| New | +$2.57M | 0.03% | 199 |
|
Other funds holding SILK
Gilder Gagnon Howe & Co's SILK Position: Q3 2024 in Review
Gilder Gagnon Howe & Co sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 39,372 shares — an estimated $1.06M sold.
Gilder Gagnon Howe & Co first reported a position in SILK in Q2 2019 and held it in 16 quarters. The position peaked at $7.91M in Q3 2020. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Gilder Gagnon Howe & Co reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Gilder Gagnon Howe & Co sold 39,372 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $1.06M.
- Gilder Gagnon Howe & Co first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 16 quarters.
- Gilder Gagnon Howe & Co's Silk Road Medical, Inc. Common Stock position peaked at $7.91M in Q3 2020.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2024, filed 14 Nov 2024.